The $3.1 billion iShares China Large-Cap (FXI), which owns the 50 largest companies that trade on the Hong Kong Stock Exchange, is down 6.6%—in large part because it excludes U.S.-listed giants like Alibaba Group Holding (BABA) and JD.com (JD).But the government has been prioritizing pharmaceuticals in the country’s economic development and the Hong Kong stock exchange has loosened its rule to allow listings of non-revenue-generating biotechs.